Flash | 04 Aug 2026 07:48:22 ET │ 11 pages Rhythm Pharmaceuticals (RYTM.O) 2Q26 First Take: HO Launch Builds on Early Momentum CITI'S TAKE Rhythm reported >400 start forms (up from >150 on 1Q26 call) have been received in the first 14 weeks of the Imcivree launch in HO, with scripts written by ~300 prescribers. WW Imcivree revenue was $71.3M for the quarter, representing 19% QoQ growth that beat our estimate of $66.6M and Factset consensus of $66.7M. US Imcivree revenue was $51.0M, an increase of 38% QoQ dr ...